Viewing Study NCT03743766


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2026-01-29 @ 3:27 PM
Study NCT ID: NCT03743766
Status: COMPLETED
Last Update Posted: 2024-09-25
First Post: 2018-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting
Sponsor: John Kirkwood
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module